Novel pharmaceutical composition for treating allergic diseases
WO2021006604A1
Novel fusion protein and use of same
TW202100564A
A novel modified immunoglobulin fc fusion protein and use thereof
TW201930343A
Pharmaceutical composition comprising recombinant extracellular domain of IgE receptor
KR20190045081A
Modified egf protein and cosmetic composition for improvement of skin condition comprising the same
KR20190045080A
Modified egf protein with improved transdermal delivery, cosmetic composition for improvement of skin condition and pharmaceutical composition for preventing or treating skin diseases comprising the same
WO2019083256A2
Modified egf protein, production method therefor, and use thereof
KR20200044365A
Method for producing modified egf protein
KR20170124506A
Composition comprising recombinant human thyroid stimulating hormone and purification method for the recombinant human thyroid stimulating hormone
KR20170120063A
Composition comprising recombinant human thyroid stimulating hormone and production method for the recombinant human thyroid stimulating hormone
KR20170052860A
Composition comprising recombinant human thyroid stimulating hormone and purification method for the recombinant human thyroid stimulating hormone
KR20170052853A
Composition comprising recombinant human thyroid stimulating hormone and production method for the recombinant human thyroid stimulating hormone
KR20160132694A
Antibody specifically binding to cd154
KR20050032709A
Method for mass production of human follicle stimulating hormone